FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964900199> ?p ?o ?g. }

• W1964900199 endingPage "775" @default.
• W1964900199 startingPage "770" @default.
• W1964900199 abstract "The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP).Patients with CUP received carboplatin AUC 5 mg/mL a minute intravenously Day 1, gemcitabine 1000 mg/m(2) intravenously Days 1 and 8, and capecitabine 1600 mg/m(2) orally in divided doses, Days 1-14 of a 21-day cycle for up to 8 cycles. The primary endpoint of the study was objective response rate by intent-to-treat analysis.Thirty-three patients were treated (median age, 58 years; men:women ratio, 19:14). Most patients had a baseline performance status of 1. The objective response rate was 39.4% (95% CI, 22.9%-57.9%) in all patients, 36.4% in 22 patients with well to moderately differentiated adenocarcinoma, and 40.0% in 20 patients with liver metastases. Median progression-free survival time was 6.2 months (95% CI, 5.4%-8.0%), and median survival time was 7.6 months (95% CI, 6.3-14.1). One and 2-year survival rates were 35.6% and 14.2%, respectively. The most frequent grade > or =3 adverse events were neutropenia (67%), thrombocytopenia (48%), and anemia (33%).The combination of carboplatin, gemcitabine, and capecitabine is active in CUP, especially in patients with liver metastases. This regimen may be a potential therapy for CUP patients with good performance status, particularly those with a suspected origin below the diaphragm." @default.
• W1964900199 created "2016-06-24" @default.
• W1964900199 creator A5000476372 @default.
• W1964900199 creator A5011595369 @default.
• W1964900199 creator A5011817630 @default.
• W1964900199 creator A5028299369 @default.
• W1964900199 creator A5036507987 @default.
• W1964900199 creator A5066306817 @default.
• W1964900199 creator A5067170116 @default.
• W1964900199 date "2007-01-01" @default.
• W1964900199 modified "2023-10-12" @default.
• W1964900199 title "Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site" @default.
• W1964900199 cites W1531882167 @default.
• W1964900199 cites W157766120 @default.
• W1964900199 cites W1772474515 @default.
• W1964900199 cites W1818021918 @default.
• W1964900199 cites W1867318780 @default.
• W1964900199 cites W1875461519 @default.
• W1964900199 cites W1913120928 @default.
• W1964900199 cites W1963592300 @default.
• W1964900199 cites W2017129426 @default.
• W1964900199 cites W2029409133 @default.
• W1964900199 cites W2089514388 @default.
• W1964900199 cites W2099615725 @default.
• W1964900199 cites W2112126084 @default.
• W1964900199 cites W2139248078 @default.
• W1964900199 cites W2149689931 @default.
• W1964900199 cites W2167481707 @default.
• W1964900199 cites W2186962695 @default.
• W1964900199 cites W2268185737 @default.
• W1964900199 cites W2270395914 @default.
• W1964900199 doi "https://doi.org/10.1002/cncr.22857" @default.
• W1964900199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17594717" @default.
• W1964900199 hasPublicationYear "2007" @default.
• W1964900199 type Work @default.
• W1964900199 sameAs 1964900199 @default.
• W1964900199 citedByCount "26" @default.
• W1964900199 countsByYear W19649001992012 @default.
• W1964900199 countsByYear W19649001992013 @default.
• W1964900199 countsByYear W19649001992015 @default.
• W1964900199 countsByYear W19649001992016 @default.
• W1964900199 countsByYear W19649001992017 @default.
• W1964900199 countsByYear W19649001992022 @default.
• W1964900199 countsByYear W19649001992023 @default.
• W1964900199 crossrefType "journal-article" @default.
• W1964900199 hasAuthorship W1964900199A5000476372 @default.
• W1964900199 hasAuthorship W1964900199A5011595369 @default.
• W1964900199 hasAuthorship W1964900199A5011817630 @default.
• W1964900199 hasAuthorship W1964900199A5028299369 @default.
• W1964900199 hasAuthorship W1964900199A5036507987 @default.
• W1964900199 hasAuthorship W1964900199A5066306817 @default.
• W1964900199 hasAuthorship W1964900199A5067170116 @default.
• W1964900199 hasBestOaLocation W19649001992 @default.
• W1964900199 hasConcept C121608353 @default.
• W1964900199 hasConcept C126322002 @default.
• W1964900199 hasConcept C141071460 @default.
• W1964900199 hasConcept C143998085 @default.
• W1964900199 hasConcept C197934379 @default.
• W1964900199 hasConcept C203092338 @default.
• W1964900199 hasConcept C2776694085 @default.
• W1964900199 hasConcept C2777063308 @default.
• W1964900199 hasConcept C2777909004 @default.
• W1964900199 hasConcept C2778239845 @default.
• W1964900199 hasConcept C2778248108 @default.
• W1964900199 hasConcept C2780258809 @default.
• W1964900199 hasConcept C2781413609 @default.
• W1964900199 hasConcept C2781451048 @default.
• W1964900199 hasConcept C29730261 @default.
• W1964900199 hasConcept C31760486 @default.
• W1964900199 hasConcept C526805850 @default.
• W1964900199 hasConcept C535046627 @default.
• W1964900199 hasConcept C71924100 @default.
• W1964900199 hasConcept C90924648 @default.
• W1964900199 hasConceptScore W1964900199C121608353 @default.
• W1964900199 hasConceptScore W1964900199C126322002 @default.
• W1964900199 hasConceptScore W1964900199C141071460 @default.
• W1964900199 hasConceptScore W1964900199C143998085 @default.
• W1964900199 hasConceptScore W1964900199C197934379 @default.
• W1964900199 hasConceptScore W1964900199C203092338 @default.
• W1964900199 hasConceptScore W1964900199C2776694085 @default.
• W1964900199 hasConceptScore W1964900199C2777063308 @default.
• W1964900199 hasConceptScore W1964900199C2777909004 @default.
• W1964900199 hasConceptScore W1964900199C2778239845 @default.
• W1964900199 hasConceptScore W1964900199C2778248108 @default.
• W1964900199 hasConceptScore W1964900199C2780258809 @default.
• W1964900199 hasConceptScore W1964900199C2781413609 @default.
• W1964900199 hasConceptScore W1964900199C2781451048 @default.
• W1964900199 hasConceptScore W1964900199C29730261 @default.
• W1964900199 hasConceptScore W1964900199C31760486 @default.
• W1964900199 hasConceptScore W1964900199C526805850 @default.
• W1964900199 hasConceptScore W1964900199C535046627 @default.
• W1964900199 hasConceptScore W1964900199C71924100 @default.
• W1964900199 hasConceptScore W1964900199C90924648 @default.
• W1964900199 hasIssue "4" @default.
• W1964900199 hasLocation W19649001991 @default.
• W1964900199 hasLocation W19649001992 @default.
• W1964900199 hasLocation W19649001993 @default.
• W1964900199 hasOpenAccess W1964900199 @default.

• next